Sensyne grows medical research dataset to 60 million patients
Deep longitudinal, disease agnostic structured global dataset, covering over 4,000 indications will industrialize Sensyne’s life sciences activities OXFORD, England–(BUSINESS WIRE)–Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the ethical Clinical AI company, today announces that it has reached a milestone of access to a combined clinical research, clinical trial and real […]